NIH-funded research NIH-funded research

Understanding how viruses that infect bacteria affect gut health

Official title: From cells to communities: The multi-scale impacts of bacteriophages in the gut microbiome

Funded at University of Wisconsin-Madison · NIH-10873199 · Data updated 2026-11-12

This study is looking at how certain viruses that target bacteria, called bacteriophages, work in our gut and how they might help us fight infections that don't respond to antibiotics, which could lead to better treatments for everyone.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$388,750
NIH project number5R35GM150996-02
Project IDNIH-10873199 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from gastrointestinal disorders or infections that are resistant to standard antibiotic treatments.

Less likely to help

Patients who do not have gastrointestinal issues or are not affected by antibiotic-resistant infections may not benefit from this research.

What this research studies

This research investigates the role of bacteriophages, which are viruses that infect bacteria, in the human gut microbiome. It aims to explore how these phages interact with bacteria and the overall microbial community, particularly in the context of antibiotic resistance. By employing advanced data generation and analysis methods, the research seeks to uncover the dynamics of phage-bacteria interactions and their implications for gut health. This knowledge could lead to improved therapeutic strategies, such as phage therapy, to combat antibiotic-resistant infections.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for infections caused by antibiotic-resistant bacteria, improving patient outcomes.

How similar studies have gone: Previous research has shown promise in using phage therapy to treat bacterial infections, indicating that this approach could be a viable solution to antibiotic resistance.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Hryckowian, Andrew John — University of Wisconsin-Madison
  • Study coordinator: Hryckowian, Andrew John

Related research

Other NIH-funded projects on the same topics.

  • Multi-agent AI to annotate enzymes in the human gut microbiome

    A team at a major university will build an AI system that automatically curates and labels the functions of enzymes in the human gut microbiome to speed up understanding their health effects.

    NIH research University of South Florida · Tampa, United States · NIH-11594384

  • Mapping how gut bacteria transform drugs

    Scientists will study how the gut microbiome changes thousands of drugs into new forms, which could affect how well a medicine works or whether it causes side effects.

    NIH research Stanford University · Stanford, United States · NIH-11550022

  • Aflatoxin exposure and child growth in Guatemala

    A study in rural Guatemala will track how exposure to aflatoxin relates to growth and gut health in young children.

    NIH research Arizona State University-Tempe Campus · Scottsdale, United States · NIH-11513260

  • Gut bacteria that can make cancer immunotherapy less effective

    This project will see if reducing chronic inflammation driven by certain gut bacteria can help immunotherapy work better for people whose cancers have stopped responding.

    NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11478145

  • How gut bacteria affect how cancer drugs work

    This project looks at how the bacteria in your gut might change how well and with what side effects fluoropyrimidine cancer drugs like 5-FU work in people.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473234

  • Gut bacteria and cancer drugs: how your gut may change chemotherapy effectiveness

    This project studies how the gut microbiome might affect how well certain chemotherapy drugs work and their side effects in people with cancer.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-11473233

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.